Over the past decade, several tumor-based predictors of cetuximab efficacy have been identified, yet most function as ...

REDWOOD CITY, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted ...

The mean monthly screening volume increased 955% in individuals aged 45 to 49 years, compared to 46% in individuals aged 50 to 75 years, study researchers reported.

Facility-based colorectal cancer screening among young adults in the U.S. has become more prevalent since medical guidelines lowered the recommended age to begin CRC screening to 45, according to ...

Circ-EGFR was identified as a novel predictive biomarker for cetuximab efficacy in KRAS wild-type metastatic colorectal ...

- QTX3034 monotherapy and the QTX3034-cetuximab combination demonstrated favorable safety profiles and clear clinical proof of concept, including confirmed responses in CRC, PDAC, and endometrial ...

America spends billions every year on standardized testing — but is it really improving education? In this bold and insightful talk, educator Tanishia Lavette Williams exposes how testing culture has ...

RADNOR, Pa., and SOUTH SAN FRANCISCO, Calif., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately held, clinical-stage biopharmaceutical company leading the development of innovative ...

California Resources Corporation (CRC) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in ...

SAN ANTONIO – Beginning Monday, anyone applying for naturalized citizenship in the United States will need to study a new version of the naturalization civics test, more commonly referred to as the ...